Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Charles River Laboratories International Inc shares valued at $1,275,000 were purchased by WALLMAN RICHARD F on Jul 21 ’25. At $150.00 per share, WALLMAN RICHARD F acquired 8,500 shares.
Also, WALLMAN RICHARD F purchased 4,000 shares, netting a total of over 550,000 in proceeds.
Before that, MASSARO GEORGE had sold 140 shares from its account. In a trade valued at $19,260, the Director traded Charles River Laboratories International Inc shares for $137.57 each. Upon closing the transaction, the insider’s holdings decreased to 140 shares, worth approximately $0.98 million.
As published in a research note from Citigroup on July 09, 2025, Charles River Laboratories International Inc [CRL] has been rated up from a Neutral to a Buy and the price target has been revised to $200. Analysts at Redburn Atlantic upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late May. As of May 14, 2025, TD Cowen has increased its “Hold” rating to a “Buy” for CRL. Earlier on May 08, 2025, Evercore ISI upgraded its rating. Their new recommendation was “an Outperform” for CRL stock which previously was a “an In-line”.
Analyzing CRL Stock Performance
On last trading session,, Charles River Laboratories International Inc [NYSE: CRL] plunged -1.27% to $176.19. The stock’s lowest price that day was $174.21, but it reached a high of $180.0163 in the same session. During the last five days, there has been a surge of approximately 4.91%. Over the course of the year, Charles River Laboratories International Inc shares have dropped approximately -24.53%.
Support And Resistance Levels for Charles River Laboratories International Inc (CRL)
RSI (Relative Strength Index) is 68.03 on the 14-day chart, showing neutral technical sentiment.
Is Charles River Laboratories International Inc subject to short interest?
Stocks of Charles River Laboratories International Inc saw a sharp steep in short interest on 2025-07-15 dropping by -0.29 million shares to 2.32 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 2.61 million shares. A decline of -12.55% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.86 of the overall float, the days-to-cover ratio (short ratio) decline to 2.86.
Which companies own the most shares of Charles River Laboratories International Inc (CRL)?
In terms of Charles River Laboratories International Inc share price expectations, FactSet research, analysts set an average price target of 290 in the next 12 months, up nearly 62.51% from the previous closing price of $178.45. Analysts anticipate Charles River Laboratories International Inc stock to reach 465 by 2025, with the lowest price target being 151. In spite of this, 9 analysts ranked Charles River Laboratories International Inc stock as Buy at the end of 2025. On March 21, 2025, Goldman assigned a price target of “a Neutral” to the stock and downgraded coverage with a $170.
